CV Lattes
Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas (FCF) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Rodrigo Gabriel Simas in research grants and scholarships supported by FAPESP.
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Acute Lymphoblastic Leukaemia (ALL) is a haematological cancer, predominantly in children. The enzyme L-Asparaginase (ASNase) is used in all standard protocols to treat this disease, resulting in a near 90% cure rate in children. The Brazilian government provides ASNase free of charge for the ALL treatment, but because ASNase is not manufactured in Brazil, the entire national demand must …
Acute lymphoblastic leukaemia (ALL) is a haematological cancer, predominantly in children. The enzyme L-Asparaginase (ASNase) is used in all standard protocols to treat ALL, resulting in a near 90% cure rate in children. The main objective of the present PhD project (FAPESP process 2018/24926-3) is to develop an industrially attractive bioprocess for native Escherichia coli ASNase product…
| 1 / 1 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 2 / 2 | All Scholarships |
| Associated processes | |